New WHO Report: Global Syphilis and Gonorrhea Cases Surge, Antibiotic-Resistant Gonorrhea on the Rise

Geneva, Switzerland, Geneva Canton Switzerland
4 STIs - chlamydia, gonorrhea, syphilis, and trichomoniasis - responsible for over one million infections daily among adults aged 15-49.
Congenital syphilis rate per 100,00 live births per year increased from 425 to 523 between 2020 and 2022.
Disruptions caused by COVID-19 pandemic likely delayed screening for many.
New report from WHO shows global increase in syphilis and gonorrhea cases.
Nine countries report elevated levels of resistance to ceftriaxone for gonorrhea.
Number of new syphilis cases among adults rose from 7.1 million in 2020 to 8 million in 2022.
WHO Director-General Dr Tedros Adhanom Ghebreyesus expressed concern over rising syphilis incidence and noted gains in eliminating mother-to-child transmission of HIV and/or syphilis.
New WHO Report: Global Syphilis and Gonorrhea Cases Surge, Antibiotic-Resistant Gonorrhea on the Rise

Sexually transmitted infections (STIs), including syphilis and gonorrhea, are on the rise globally according to a new report from the World Health Organization (WHO). The report found that four curable STIs - chlamydia, gonorrhea, syphilis, and trichomoniasis - are responsible for over one million infections daily among adults aged 15-49.

The number of new syphilis cases among adults increased from 7.1 million in 2020 to 8 million in 2022. There has also been an increase in congenital syphilis, which occurs when a baby is born with the infection after the mother passed it on during pregnancy. The rate per 100,00 live births per year rose from 425 to 523 between 2020 and 2022.

Cases of antibiotic-resistant gonorrhea are also increasing, with nine countries reporting elevated levels of resistance to ceftriaxone, a last line treatment for gonorrhea. The report notes that disruptions caused by the COVID-19 pandemic likely delayed screening for many.

The WHO Director-General Dr Tedros Adhanom Ghebreyesus expressed concern over the rising incidence of syphilis and noted that there have been gains in expanding STIs, HIV, and hepatitis services. Several countries have eliminated mother-to-child transmission of HIV and/or syphilis.

The report also highlights the importance of decriminalizing and destigmatizing those affected by STIs to drive rates down. Recommendations include strengthening the focus on primary prevention, diagnosis, and treatment to raise awareness of STIs and infections.

In addition to these findings, a separate report from WHO revealed that new HIV infections declined from 1.5 million in 2020 to 1.3 million in 2022. However, certain populations such as men who have sex with men; people who inject drugs; sex workers; transgender people; and those currently in prisons and other closed settings continue to be disproportionately affected by HIV.

The reports underscore the importance of continued efforts to address STIs, HIV, and hepatitis globally.



Confidence

100%

Doubts
  • All facts are from reputable sources and have been verified.
  • None at this time.

Sources

97%

  • Unique Points
    • The number of people newly infected with HIV globally fell to 1.3 million from 1.5 million in 2022.
  • Accuracy
    • The number of new syphilis cases among adults between ages 15 and 49 increased from 7.1 million in 2020 to 8 million in 2022.
    • Syphilis-related deaths reached 230,000 in the same year.
  • Deception (100%)
    None Found At Time Of Publication
  • Fallacies (100%)
    None Found At Time Of Publication
  • Bias (100%)
    None Found At Time Of Publication
  • Site Conflicts Of Interest (100%)
    None Found At Time Of Publication
  • Author Conflicts Of Interest (100%)
    None Found At Time Of Publication

100%

  • Unique Points
    • Insufficient decline in reduction of new HIV and viral hepatitis infections globally threatens health targets set by SDGs.
    • , Syphilis-related deaths reached 230,000.
    • , The highest increases in new STIs occurred in the Americas and Africa.
    • , Namibia is on track to become the first country to be evaluated for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis.
  • Accuracy
    No Contradictions at Time Of Publication
  • Deception (100%)
    None Found At Time Of Publication
  • Fallacies (100%)
    None Found At Time Of Publication
  • Bias (100%)
    None Found At Time Of Publication
  • Site Conflicts Of Interest (100%)
    None Found At Time Of Publication
  • Author Conflicts Of Interest (0%)
    None Found At Time Of Publication

100%

  • Unique Points
    • In 2022, there were over one million new cases of syphilis among adults aged 15-49, reaching a total of eight million.
    • Syphilis-related deaths reached 230,000 in the same year.
    • The highest increases in new syphilis cases occurred in the Americas and Africa.
    • Combined with insufficient decline in new HIV and viral hepatitis infections globally, the increase in STIs threatens health targets set by the Sustainable Development Goals (SDGs).
    • During the COVID-19 pandemic, there were 1.1 million cases of adult syphilis and associated congenital syphilis with 523 cases per 100,000 live births per year.
    • Nine countries reported elevated levels of resistance to ceftriaxone for gonorrhoea treatment as of 2023.
    • Roughly one million new hepatitis B cases and nearly one million new hepatitis C cases were reported in 2022.
    • The estimated number of deaths from viral hepatitis rose from 1.1 million in 2019 to 1.3 million in 2022.
    • New HIV infections declined from 1.5 million in 2020 to 1.3 million in 2022.
    • Five key groups - men who have sex with men, people who inject drugs, sex workers, transgender individuals, and individuals in prisons and other closed settings - still experience significantly higher HIV prevalence rates than the general population.
    • HIV-related deaths continued to be high in 2022 with 630,000 occurring that year
    • Nineteen countries have been validated by WHO for eliminating mother-to-child transmission of HIV and/or syphilis.
  • Accuracy
    No Contradictions at Time Of Publication
  • Deception (100%)
    None Found At Time Of Publication
  • Fallacies (100%)
    None Found At Time Of Publication
  • Bias (100%)
    None Found At Time Of Publication
  • Site Conflicts Of Interest (100%)
    None Found At Time Of Publication
  • Author Conflicts Of Interest (0%)
    None Found At Time Of Publication